Novartis BP drug sees approval in Europe
Marc Iskowitz
August 27 2007
The European Commission approved Novartis Rasilez (aliskiren) for use in the European Union.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.